MGMT-Methylated Glioblastoma Clinical Trials

7 clinical trials for MGMT-Methylated Glioblastoma across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma — RECRUITING · PHASE2
• G-CSF After Chemo-radiation in Patients With Glioblastoma — RECRUITING · PHASE2
• Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma — RECRUITING · PHASE3
• DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma — RECRUITING · PHASE1
• STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation — NOT_YET_RECRUITING · PHASE2
• Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients — COMPLETED · PHASE1
• 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) — WITHDRAWN

Refine this search